Follow along with the Gizmodo crew as we unpack everything Google announces at its annual developer conference in Mountain View, Calif.
George Orwell's still-timely 80-year-old allegory comes to life in a new animated film also starring Gaten Matarazzo, Kieran Culkin, and more.
QAnon folks are bending over backwards to support their boys.
The Robert Jordan adaptation was recently cancelled after three seasons at Amazon.
Apple's iOS 26 (yes, you read that right) may feature the same see-through bubble UI as the rest of Apple's ecosystem.
Tom Hiddleston leads an all-star cast in this Mike Flanagan adaptation of a novella by Stephen King, opening wide June 13.
If Apple is going to address its stumbles with AI, now would be the time, but my hopes aren't super high.
There probably aren't many miles on the thing.
Disney already announced new attractions for 'Coco' and 'Avatar' but now we know where they're going, and what's leaving.
Although OpenAI has continually slammed the New York Times' copyright lawsuit, the case isn't as meritless as the company claims.
The 'Pearl' and 'X' actress joins Ryan Gosling in the Shawn Levy film coming in 2027.
The animated anthology movie directed by Dan Trachtenberg is now on Hulu.
Thousands of people, mostly children, in the U.S., Canada, and Mexico have contracted the vaccine-preventable disease this year.
After nearly a decade away from fighting games, Marvel's making a comeback with Arc System Works' 'Marvel Tōkon: Fighting Souls.'
We found out the hard way just how bad Switch 2 DRM can get.
Now you don't have to feel sad about Brasso getting got when you're looking for some of that Rebel bass.
The Resilience lander was carrying a tiny rover, a miniature Swedish cottage, and several science payloads when it crashed onto the lunar surface.
Will a new federal probe reveal that DEI is to blame for air disasters?
The fallen NASA administrator nominee was clearly not a fan of the agency's plan to return astronauts to the Moon.
The petition urges the agency to do away with an “unnecessary” and “burdensome” regulatory framework that significantly limits access to this medication.
